HALO logo
halo search icon
Nuvalent, Inc. Class A
Nuvalent, Inc. Class A
NUVL · NAS

Nuvalent, Inc. Class A

US$102.32

Price Arrow1.32 (1.31%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusFakey Shakey - LongHALO All
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Nuvalent, Inc. Class A Overview

NUVL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

About NUVL

icon

Website

Nuvalent, Inc. Class A

icon

Telephone

1.857.357.7000

icon

Address

14th floor, One Broadway, Cambridge, MA 02142

Description

Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC. The company was founded by Matthew D. Shair in January 2017 and is headquartered in Cambridge, MA.

NUVL Price Chart

Key Stats

Market Cap

US$7.43B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 70.25 - 113.01

Trade Value (12mth)

US$12,733,394.00

1 week

-1.27%

1 month

-5.72%

YTD

0.16%

1 year

37.12%

All time high

113.51

Key Fundamentals

EPS 3 yr Growth

255.10%

EBITDA Margin

0.00%

Operating Cashflow

-$275m

Free Cash Flow Return

-23.70%

ROIC

-36.70%

Interest Coverage

0.00

Quick Ratio

15.30

Other Data

Shares Outstanding (Fully Diluted)

79m

HALO Sector

Healthcare

Next Company Report Date

04-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

NUVL Announcements

Latest Announcements

DateAnnouncements
07 May 26
07 May 26
07 May 26
07 April 26
26 February 26

NUVL Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-2.17-3.93-5.85locklocklock
EPS (Fully Diluted)
$locklocklocklock-2.17-3.93-5.85locklocklock
Growth
%locklocklocklock-31.5-81.1-49locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Nuvalent, Inc. Class A (NUVL:NAS)?
Halo FAQ
The current share price of Nuvalent, Inc. Class A (NUVL:NAS) is USD$102.32.
What is the 52-week high share price for Nuvalent, Inc. Class A (NUVL:NAS)?
Halo FAQ
The 52-week high share price for Nuvalent, Inc. Class A (NUVL:NAS) is USD$113.01.
What is the 52-week low share price for Nuvalent, Inc. Class A (NUVL:NAS)?
Halo FAQ
The 52-week low share price for Nuvalent, Inc. Class A (NUVL:NAS) is USD$70.25.
What is the dividend yield for Nuvalent, Inc. Class A (NUVL:NAS)?
Halo FAQ
Nuvalent, Inc. Class A (NUVL:NAS) does not pay a dividend.
What was Nuvalent, Inc. Class A (NUVL:NAS) last dividend payment?
Halo FAQ
Nuvalent, Inc. Class A (NUVL:NAS) does not pay a dividend.
What is the franking level for Nuvalent, Inc. Class A (NUVL:NAS)?
Halo FAQ
Nuvalent, Inc. Class A (NUVL:NAS) has a franking level of 0.00%.
In which sector is Nuvalent, Inc. Class A (NUVL:NAS) classified?
Halo FAQ
Nuvalent, Inc. Class A (NUVL:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.